327 related articles for article (PubMed ID: 25509060)
1. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
[TBL] [Abstract][Full Text] [Related]
2. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
[TBL] [Abstract][Full Text] [Related]
3. Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs.
Fantasia HC; Harris AL
Nurs Womens Health; 2015; 19(3):266-70. PubMed ID: 26058910
[TBL] [Abstract][Full Text] [Related]
4. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
Ramoz LL; Patel-Shori NM
Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
[TBL] [Abstract][Full Text] [Related]
5. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
Tassinari MS; Sahin L; Yao LP
Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):718-20. PubMed ID: 26223007
[TBL] [Abstract][Full Text] [Related]
6. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
[TBL] [Abstract][Full Text] [Related]
7. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
Gruber MF
Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
[TBL] [Abstract][Full Text] [Related]
8. Medication use in pregnancy and the pregnancy and lactation labeling rule.
Sahin L; Nallani SC; Tassinari MS
Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
[TBL] [Abstract][Full Text] [Related]
9. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
[TBL] [Abstract][Full Text] [Related]
10. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
Beroukhim K; Abrouk M; Farahnik B
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
[TBL] [Abstract][Full Text] [Related]
11. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
[TBL] [Abstract][Full Text] [Related]
12. Understanding the new pregnancy and lactation drug labeling.
Watkins EJ; Archambault M
JAAPA; 2016 Feb; 29(2):50-2. PubMed ID: 26818647
[TBL] [Abstract][Full Text] [Related]
13. Introduction to the new prescription drug labeling by the Food and Drug Administration.
Lal R; Kremzner M
Am J Health Syst Pharm; 2007 Dec; 64(23):2488-94. PubMed ID: 18029957
[TBL] [Abstract][Full Text] [Related]
14. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526
[TBL] [Abstract][Full Text] [Related]
15. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
[TBL] [Abstract][Full Text] [Related]
16. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
17. Exceptions or alternatives to labeling requirements for products held by the Strategic National Stockpile. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2012 Feb; 77(24):5696-9. PubMed ID: 22359804
[TBL] [Abstract][Full Text] [Related]
18. FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use.
Feibus KB
J Med Toxicol; 2008 Dec; 4(4):284-8. PubMed ID: 19031382
[TBL] [Abstract][Full Text] [Related]
19. Clinicians' Perspective of the New Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI/FDA Survey.
Namazy J; Chambers C; Sahin L; Johnson T; Dinatale M; Lappin B; Schatz M
J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1947-1952. PubMed ID: 32084595
[TBL] [Abstract][Full Text] [Related]
20. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling.
Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L
J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
